AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24313546 — intervention group
Group type: COMPARATOR
Intervention: Control cluster group
Number of subjects: 42
Study 20597141 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil (10 mg/day over 24 weeks)
Number of subjects: 0
Study 20597141 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16002019 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose oral ciprofloxacin (500 mg)
Number of subjects: 395
Study 16002019 — intervention group
Group type: COMPARATOR
Intervention: Single-dose intravenous cefazolin (1g)
Number of subjects: 395
Study 16002019 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 395
Study 12022620 — intervention group
Group type: COMPARATOR
Intervention: Magnetization transfer ratio (MTR) histogram analysis using linear discriminant analysis (LDA) for classification of MS subgroups.
Number of subjects: 0
Study 12022620 — intervention group
Group type: COMPARATOR
Intervention: Principal component analysis (PCA) for correlation with current disability measured by the EDSS scale.
Number of subjects: 0
Study 10078798 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI)
Number of subjects: 229
Study 10078798 — intervention group
Group type: COMPARATOR
Intervention: Simple Advice (SA)
Number of subjects: 229
Study 7805081 — intervention group
Group type: EXPERIMENTAL
Intervention: Less intense anticoagulant regimens with or without concomitant antiplatelet therapy
Number of subjects: 0
Study 7805081 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral anticoagulants for tissue valves
Number of subjects: 0
Study 7805081 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral anticoagulants for mechanical valves
Number of subjects: 0
Study 2783701 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg)
Number of subjects: 18
Study 2783701 — intervention group
Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 18
Study 1012648 — intervention group
Group type: EXPERIMENTAL
Intervention: VP-16
Number of subjects: 39
Study 1012648 — intervention group
Group type: EXPERIMENTAL
Intervention: VCR plus ADR
Number of subjects: 39
Study 1012648 — intervention group
Group type: COMPARATOR
Intervention: Crossover from VP-16 to VCR plus ADR
Number of subjects: 39
Study 1012648 — intervention group
Group type: COMPARATOR
Intervention: Crossover from VCR plus ADR to VP-16
Number of subjects: 39
Study 1012648 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment programs
Number of subjects: 39
Study 14725502 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental groups (group I, II, III)
Number of subjects: 50
Study 14725502 — intervention group
Group type: COMPARATOR
Intervention: Control group (group IV)
Number of subjects: 50
Study 29767376 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Employment Success Tool (IEST™)
Number of subjects: 84
Study 29767376 — intervention group
Group type: COMPARATOR
Intervention: Support as usual
Number of subjects: 84
Study 27687346 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-controlled ventilation-volume guaranteed (PCV-VG)
Number of subjects: 40
Study 27687346 — intervention group
Group type: COMPARATOR
Intervention: Volume controlled ventilation (VCV)
Number of subjects: 40
Study 24916555 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry leaf extract beverage
Number of subjects: 12
Study 24916555 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie cranberry juice cocktail (LCJC)
Number of subjects: 12
Study 24916555 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 24916555 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry beverages (both types)
Number of subjects: 12
Study 22264219 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental enrichment intervention during rehabilitation
Number of subjects: 0
Study 22264219 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental enrichment intervention
Number of subjects: 0
Study 22264219 — intervention group
Group type: COMPARATOR
Intervention: Usual rehabilitation environment (control)
Number of subjects: 0
Study 22477921 — intervention group
Group type: EXPERIMENTAL
Intervention: Training of primary care and community health workers about mental health
Number of subjects: 1877
Study 18415809 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation for medical group
Number of subjects: 1218
Study 18415809 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation for surgical group
Number of subjects: 1218
Study 18415809 — intervention group
Group type: COMPARATOR
Intervention: Lung volume reduction surgery (LVRS)
Number of subjects: 1218
Study 18415809 — intervention group
Group type: COMPARATOR
Intervention: Factors affecting adherence to rehabilitation
Number of subjects: 1218
Study 18415809 — intervention group
Group type: EXPERIMENTAL
Intervention: Mortality and maximal exercise capacity
Number of subjects: 1218
Study 15621326 — intervention group
Group type: EXPERIMENTAL
Intervention: Tandem stance for 30 seconds in healthy elderly adults
Number of subjects: 53
Study 15621326 — intervention group
Group type: EXPERIMENTAL
Intervention: Tandem stance for 30 seconds in healthy young adults
Number of subjects: 53
Study 15621326 — intervention group
Group type: COMPARATOR
Intervention: Both groups during tandem stance
Number of subjects: 53
Study 12177586 — intervention group
Group type: EXPERIMENTAL
Intervention: Agomelatine 25 mg once a day
Number of subjects: 711
Study 12177586 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 711
Study 12177586 — intervention group
Group type: COMPARATOR
Intervention: Agomelatine (1 mg, 5 mg, 25 mg)
Number of subjects: 711
Study 10457138 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual tangential pressure over the perilesional skin before biopsy (Group A)
Number of subjects: 74
Study 10457138 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsy without tangential pressure technique (Group B)
Number of subjects: 74
Study 10457138 — intervention group
Group type: COMPARATOR
Intervention: Tangential pressure technique before biopsy (Group C - control)
Number of subjects: 74
Study 7610473 — intervention group
Group type: EXPERIMENTAL
Intervention: Isocaloric enteral feeding with 52 gr protein for 2000 kcal
Number of subjects: 67
Study 7610473 — intervention group
Group type: EXPERIMENTAL
Intervention: Isocaloric enteral feeding with 35 gr protein for 2000 kcal
Number of subjects: 67
Study 7610473 — intervention group
Group type: EXPERIMENTAL
Intervention: Isocaloric enteral feeding with 80 gr protein for 2000 kcal
Number of subjects: 67
Study 7610473 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily administration of 50 gr protein for 2000 kcal
Number of subjects: 67
Study 2231217 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride (7.5 to 10 mg) three times daily for 6 months
Number of subjects: 17
Study 2231217 — intervention group
Group type: COMPARATOR
Intervention: Placebo three times daily for 6 months
Number of subjects: 17
Study 302373 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP) 2 Gm administered 1/2 hour prior to cardiopulmonary bypass (CPB)
Number of subjects: 150
Study 302373 — intervention group
Group type: COMPARATOR
Intervention: Control group (no MP treatment)
Number of subjects: 150
Study 31090968 — intervention group
Group type: EXPERIMENTAL
Intervention: Potential financial incentives for meeting performance goals
Number of subjects: 0
Study 31090968 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly alerts to providers
Number of subjects: 0
Study 31090968 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (financial incentives and weekly alerts)
Number of subjects: 0
Study 31090968 — intervention group
Group type: COMPARATOR
Intervention: Control group (no interventions)
Number of subjects: 0
Study 31402292 — intervention group
Group type: EXPERIMENTAL
Intervention: NIPPV
Number of subjects: 56
Study 31402292 — intervention group
Group type: COMPARATOR
Intervention: Nasal cannula (control)
Number of subjects: 56
Study 27207449 — intervention group
Group type: EXPERIMENTAL
Intervention: DMF 240 mg BID
Number of subjects: 0
Study 27207449 — intervention group
Group type: EXPERIMENTAL
Intervention: DMF 240 mg TID
Number of subjects: 0
Study 27207449 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 0
Study 27207449 — intervention group
Group type: COMPARATOR
Intervention: Glatiramer acetate (GA)
Number of subjects: 0
Study 25790673 — intervention group
Group type: EXPERIMENTAL
Intervention: Nourishing Xin and Shen method (NXSM)
Number of subjects: 54
Study 25790673 — intervention group
Group type: COMPARATOR
Intervention: Donepezil hydrochloride
Number of subjects: 54
Study 25790673 — intervention group
Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 54
Study 23521816 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical parameters
Number of subjects: 1015
Study 23521816 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine laboratory markers
Number of subjects: 1015
Study 23521816 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific biomarkers
Number of subjects: 1015
Study 21644304 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture with needle-retaining time of 30 min (120 min total)
Number of subjects: 52
Study 21644304 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture with needle-retaining time of 10 min (40 min total)
Number of subjects: 52
Study 18725185 — intervention group
Group type: EXPERIMENTAL
Intervention: Dim Light Melatonin Onset (DLMO) Test
Number of subjects: 56
Study 16673682 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief physiotherapy intervention
Number of subjects: 268
Study 16673682 — intervention group
Group type: COMPARATOR
Intervention: Usual physiotherapy
Number of subjects: 268
Study 15063428 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (n = 28)
Number of subjects: 87
Study 15063428 — intervention group
Group type: COMPARATOR
Intervention: Bezafibrate (n = 30)
Number of subjects: 87
Study 15063428 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultured ECs stimulated with TNF-alpha
Number of subjects: 87
Study 11534937 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-thickened fluids
Number of subjects: 24
Study 11534937 — intervention group
Group type: COMPARATOR
Intervention: Powder-thickened fluids
Number of subjects: 24
Study 9130688 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-Aza-2'-deoxycytidine combined with amsacrine (n=30)
Number of subjects: 63
Study 8179230 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate, 200 micrograms, twice daily
Number of subjects: 90
Study 8179230 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate, 200 micrograms, once daily
Number of subjects: 90
Study 3328342 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether
Number of subjects: 62
Study 3328342 — intervention group
Group type: COMPARATOR
Intervention: Quinine
Number of subjects: 62
Study 29601511 — intervention group
Group type: EXPERIMENTAL
Intervention: Height-adaptive step length measurement method
Number of subjects: 30
Study 27797787 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity pulsed ultrasound (LIPUS)
Number of subjects: 501
Study 27797787 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 501
Study 25095718 — intervention group
Group type: COMPARATOR
Intervention: Transarterial chemoembolization (TACE)
Number of subjects: 24
Study 25095718 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective internal radiotherapy (SIRT)
Number of subjects: 24
Study 23570437 — intervention group
Group type: EXPERIMENTAL
Intervention: Degarelix
Number of subjects: 0
Study 23570437 — intervention group
Group type: COMPARATOR
Intervention: Leuprolide
Number of subjects: 0
Study 20503397 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplement containing isoflavones and curcumin
Number of subjects: 85
Study 17532166 — intervention group
Group type: EXPERIMENTAL
Intervention: PSE using PVA particles
Number of subjects: 60
Study 17532166 — intervention group
Group type: COMPARATOR
Intervention: PSE using gelfoam particles
Number of subjects: 60
Study 17532166 — intervention group
Group type: EXPERIMENTAL
Intervention: PSE using PVA particles and gelfoam particles
Number of subjects: 60
Study 16226371 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate 0.3mg/kg per dose PO BID from the second day of admission until discharge
Number of subjects: 80
Study 16226371 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 12645716 — intervention group
Group type: EXPERIMENTAL
Intervention: PMEA-coated circuits (group P)
Number of subjects: 22
Study 12645716 — intervention group
Group type: COMPARATOR
Intervention: Uncoated circuits (group U)
Number of subjects: 22
Study 10389911 — intervention group
Group type: EXPERIMENTAL
Intervention: HER-2/neu peptide-based vaccine
Number of subjects: 8
Study 8916623 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for anxiety disorders
Number of subjects: 151
Study 8916623 — intervention group
Group type: COMPARATOR
Intervention: Control group (80 participants)
Number of subjects: 151
Study 1876247 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecally administered morphine 0.125 mg
Number of subjects: 56
Study 1876247 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecally administered morphine 0.25 mg
Number of subjects: 56
Study 1876247 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecally administered morphine 0.5 mg
Number of subjects: 56
Study 1876247 — intervention group
Group type: COMPARATOR
Intervention: Systemic narcotic administration
Number of subjects: 56
Study 6819276 — intervention group
Group type: EXPERIMENTAL
Intervention: 14 MeV d + T fast neutrons; Dosage: 18 to more than 22 Gy; Treatment method: two parallel opposed ports
Number of subjects: 400
Study 6819276 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose neutrons; Treatment method: randomized in a three arm trial
Number of subjects: 400
Study 6819276 — intervention group
Group type: COMPARATOR
Intervention: Neutron irradiation
Number of subjects: 400
Study 31594635 — intervention group
Group type: EXPERIMENTAL
Intervention: Relugolix (40 mg once daily for 12 weeks)
Number of subjects: 65
Study 31594635 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 28993005 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg every other week
Number of subjects: 217
Study 28993005 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 217
Study 28993005 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 217
Study 26754625 — intervention group
Group type: EXPERIMENTAL
Intervention: LCZ696
Number of subjects: 0
Study 26754625 — intervention group
Group type: COMPARATOR
Intervention: valsartan
Number of subjects: 0
Study 24122836 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin 750 mg bid
Number of subjects: 312
Study 24122836 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin 500 mg tid
Number of subjects: 312
Study 24122836 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin 500 mg qid
Number of subjects: 312
Study 24122836 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin 750 mg bid with metronidazole 250 mg bid
Number of subjects: 312
Study 24122836 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin 500 mg tid with metronidazole 250 mg bid
Number of subjects: 312
Study 24122836 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin 500 mg qid with metronidazole 250 mg bid
Number of subjects: 312
Study 21767044 — intervention group
Group type: EXPERIMENTAL
Intervention: Concrete thinking
Number of subjects: 0
Study 21767044 — intervention group
Group type: COMPARATOR
Intervention: Abstract thinking
Number of subjects: 0
Study 19842006 — intervention group
Group type: EXPERIMENTAL
Intervention: Insurance availability
Number of subjects: 3545
Study 19842006 — intervention group
Group type: EXPERIMENTAL
Intervention: Insured with eight or more doctor visits
Number of subjects: 3545
Study 19842006 — intervention group
Group type: COMPARATOR
Intervention: Uninsured
Number of subjects: 3545
Study 17536453 — intervention group
Group type: EXPERIMENTAL
Intervention: HIF-1 alpha expression in papillary thyroid carcinoma (group I)
Number of subjects: 73
Study 17536453 — intervention group
Group type: EXPERIMENTAL
Intervention: VEGF expression in papillary thyroid carcinoma (group I)
Number of subjects: 73
Study 17536453 — intervention group
Group type: EXPERIMENTAL
Intervention: VEGF-C expression in papillary thyroid carcinoma (group I)
Number of subjects: 73
Study 17536453 — intervention group
Group type: EXPERIMENTAL
Intervention: HIF-1 alpha, VEGF, and VEGF-C expression in carcinoma patients with lymph node metastasis
Number of subjects: 73
Study 17536453 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of VEGF and VEGF-C expression with HIF-1 alpha
Number of subjects: 73
Study 15334432 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term, high-intensity exercises
Number of subjects: 1191
Study 15334432 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 1191
Study 11843929 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical oxymetazoline (decongestion)
Number of subjects: 20
Study 11843929 — intervention group
Group type: COMPARATOR
Intervention: Ipsilateral isometric exercise (congestion)
Number of subjects: 20
Study 9542322 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN alpha‐2b 3 megaunits (MU) subcutaneously three times a week (group A)
Number of subjects: 52
Study 9542322 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN alpha‐2b 3 MU/day until disease progression (group B)
Number of subjects: 52
Study 9542322 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN dose > or = 30 MU/month
Number of subjects: 52
Study 9542322 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 52
Study 8117231 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspartame (NutraSweet)
Number of subjects: 0
Study 8117231 — intervention group
Group type: COMPARATOR
Intervention: Ethanol (0.1% BAL)
Number of subjects: 0
Study 3291557 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone, 150 mg four times daily
Number of subjects: 38
Study 3291557 — intervention group
Group type: COMPARATOR
Intervention: Disopyramide, 100 mg four times daily
Number of subjects: 38
Study 3291557 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone
Number of subjects: 38
Study 3291557 — intervention group
Group type: COMPARATOR
Intervention: Disopyramide
Number of subjects: 38
Study 1425004 — intervention group
Group type: EXPERIMENTAL
Intervention: Levo-praziquantel
Number of subjects: 70
Study 1425004 — intervention group
Group type: COMPARATOR
Intervention: Praziquantel
Number of subjects: 70
Study 330483 — intervention group
Group type: EXPERIMENTAL
Intervention: amoxycillin 250 mg and pivmecillinam 200 mg
Number of subjects: 132
Study 330483 — intervention group
Group type: COMPARATOR
Intervention: amoxycillin 500 mg
Number of subjects: 132
Study 330483 — intervention group
Group type: EXPERIMENTAL
Intervention: amoxycillin 500 mg and pivmecillinam 400 mg
Number of subjects: 132
Study 31547438 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium restriction (dietary counseling)
Number of subjects: 45
Study 31547438 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (50 mg daily)
Number of subjects: 45
Study 31547438 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (sodium restriction + hydrochlorothiazide)
Number of subjects: 45
Study 31547438 — intervention group
Group type: COMPARATOR
Intervention: Placebo (regular sodium intake)
Number of subjects: 45
Study 28145162 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids plus standard treatment (TMP/SMX)
Number of subjects: 78
Study 28145162 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment plus placebo
Number of subjects: 78
Study 26031955 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 51
Study 26031955 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 51
Study 24266960 — intervention group
Group type: COMPARATOR
Intervention: Intensive blood pressure lowering (target systolic < 125 mmHg)
Number of subjects: 100
Study 24266960 — intervention group
Group type: COMPARATOR
Intervention: Guideline blood pressure lowering (target systolic < 140 mmHg)
Number of subjects: 100
Study 24266960 — intervention group
Group type: COMPARATOR
Intervention: Intensive lipid lowering (target LDL-c < 1.4 mmol/l)
Number of subjects: 100
Study 24266960 — intervention group
Group type: COMPARATOR
Intervention: Guideline lipid lowering (target LDL-c < 3 mmol/l)
Number of subjects: 100
Study 24266960 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure lowering therapy for hemorrhagic stroke
Number of subjects: 100
Study 24266960 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure lowering therapy for ischemic stroke
Number of subjects: 100
Study 24266960 — intervention group
Group type: EXPERIMENTAL
Intervention: Feasibility of recruitment and retention of participants
Number of subjects: 100
Study 24266960 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolerability and safety of the interventions
Number of subjects: 100
Study 24266960 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintaining differences in systolic blood pressure (> 10 mmHg)
Number of subjects: 100
Study 24266960 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintaining differences in LDL-c (> 1 mmol/l)
Number of subjects: 100
Study 24266960 — intervention group
Group type: EXPERIMENTAL
Intervention: Performing clinic and telephone follow-up of cognition measures
Number of subjects: 100
Study 21249389 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 60% peak oxygen uptake
Number of subjects: 12
Study 21249389 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 80% peak oxygen uptake
Number of subjects: 12
Study 21249389 — intervention group
Group type: COMPARATOR
Intervention: Control condition (fixed workload at 20 W)
Number of subjects: 12
Study 20836307 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill walking exercise training (TWET)
Number of subjects: 40
Study 20836307 — intervention group
Group type: EXPERIMENTAL
Intervention: Overground walking exercise training (OWET)
Number of subjects: 40
Study 20836307 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy rehabilitation
Number of subjects: 40
Study 17194902 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic stem-cell transplantation (SCT)
Number of subjects: 106